Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
*Myrica esculenta extract* is a **plant-derived extract** from the leaves, bark, and fruits of Myrica esculenta (box myrtle/kaphal), used in ethnomedicine and investigated for its diverse pharmacological effects. The extracts contain a range of bioactive compounds such as **phenolic acids** (gallic acid, p-coumaric acid), **flavonoids** (myricetin, quercetin, catechin), **diarylheptanoids** (myricanol, myricanone), **triterpenoids** (oleanolic acid, lupeol), and **steroids** (β-sitosterol, stigmasterol). Key mechanisms include **antioxidant activity** through radical scavenging, **antimicrobial** effects against Gram-positive and Gram-negative bacteria, **anti-inflammatory** action, and **angiotensin-converting enzyme (ACE) inhibition**, suggesting possible antihypertensive activity. The extract's mechanism of action is multifactorial and is attributed to its phytochemical composition, especially the phenolics, flavonoids, and terpenoids, which modulate oxidative stress, inflammation, and the microbial membrane[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on myrica esculenta extract.